Agios Pharmaceuticals Inc. (0HB0)
Market Closed
12 Jun, 15:30
$
29. 69
+1.12
+3.9202%
$
- Market Cap
- P/E Ratio
- Div Yield
3 Volume
- Eps
$ 28.57
Previous Close Want to track 0HB0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agios Pharmaceuticals Inc. (0HB0) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.6B
Trailing P/E (ttm) -3.94
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 25.47
Price/Book (mrq) 1.5
Enterprise Value/Revenue 24.29
Enterprise Value/EBITDA -3.41
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 330
Average volume (90 days) 964
Price summary
52-Week low 22.4
52-Week high 45.81
Beta -
50-Day moving average 27.93
200-Day moving average 28.47
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.4%
Operating margin -7.2%
Operational effectiveness
Return on assets -0.36%
Return on equity -0.34%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.54
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 14.19%
Book value per share (mrq) 18.87
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
